rhIL-7-hyFc

recombinant human interleukin-7 fused to an Fc domain

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhIL-7-hyFc, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide [Phase 1, Phase 2]

See pricing